Viartril-S Powder 30's Box 1500mg

Osteoarthritis is the most common form of degenerative arthritis that affects most weight bearing joints especially the knees.

Viartril-S is the original Crystalline Glucosamine Sulfate that has been fully tested in many clinical trials with results shown in:

• Reduce pain³
• Improve joint function³
• 90% absorption by the body⁴
• Reduction in use of NSAIDS⁵
• Long-term safety and do not impair glucose metabolism⁶

Contents:

Each sachet contains:

ACTIVE INGREDIENT

Crystalline Glucosamine Sulfate             1884.0mg

equivalent to:    glucosamine sulfate       1500.0mg

                        sodium chloride               384.0mg

EXCIPIENTS

Aspartame, sorbitol, macrogol 4000, citric acid

Indication

Treatment of the symptoms of osteoarthritis, i.e. pain and function limitation.

How-to-take/ Instructions:

The content of one sachet (dissolved in a glass of water) should be taken once daily, preferably at meals.

References:

1. Reginster JY et al: Long-term effects of glucosamine sulfate on osteoarthritis progression: a randomized, placebo-controlled clinical trial. Lancet 357, 251-256 (2001)
2. Pavelka K et al: Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-years, randomized, placebo-controlled, double-blind study. Arch. Intern. Med. 162, 2113-2123 (2002)
3. Rovalti LC et al: The Clinical profile of glucosamine sulfate as a selective symptom modifying drug in osteoarthritis: Current data and perspectives. Osteoarth.Cartil.5 (suppl.A), 72 (1997)
4. Setnikar et al. Arzneimittelforschung.1993 Oct’43 (10): 1109-13
5. Rovati, L.C., Girolami, F., D’Amato, M. and Giacovelli, G., 2016, February. Effects of glucosamine sulfate on the use of rescue non-steroidal anti-inflammatory drugs in knee osteoarthritis: results from the Pharmaco-Epidemiology of GonArthroSis (PEGASus) study. In Seminars in arthritis and rheumatism, 45(4), pp.S34-S41. WB Saunders.
6. Roberto Palma et al. “Crystalline Glucosamine Sulfate in the Treatment of Osteoarthritis: Evidence of Long-Term Cardiovascular Safety from Clinical Trials” The Open Rheumatology Journal, 2011, 5, 69-77
7. Gregori D, et al. “Association of Pharmacological Treatment With Long-term Pain Control in Patients With Knee Osteoarthritis” JAMA 2018; 320(24):2564-2579